News search

    E.g., 10/11/2026
    E.g., 10/11/2026
    María Sofía Sánchez Muñoz, Rui Benedito, Irene García González, Susana da Conceição Ferreira da Rocha y Aroa García Cabero.
    Research
    4 Nov 2026
    Nature: Scientists have uncovered alternative pathways for blood vessel growth that could help overcome resistance to anti-angiogenic cancer treatments

    A study involving CNIC researchers shows that blood vessels can grow in the absence of VEGF-VEGFR2 signalling, one of the pathways most commonly targeted for therapeutic purposes in clinical practice.
    alessia_ferrarini_genomebiology
    About the CNIC
    26 Oct 2026
    Genome Biology: A new online tool developed by CNIC scientists makes it easier to integrate data and uncover the biological mechanisms behind disease
    David_Sancho
    About the CNIC
    26 Oct 2026
    David Sancho receives the 22nd Health Sciences Award from the Caja Rural Granada Foundation

    The Foundation recognises the pioneering research into the link between gut microbiota and cardiovascular disease led by David Sancho at the CNIC 
    CHAIN
    About the CNIC
    13 Oct 2026
    CNIC participates in CHAIN, a new European initiative aims to accelerate AI in cardiovascular care
    Noche_Europea_investigadores
    About the CNIC
    28 Sep 2026
    The 17th European Researchers’ Night at CNIC: A look back

    The CNIC organised five events open to the public of all ages to celebrate the 17th European Researchers’ Night
    celulas_pluripotentes
    About the CNIC
    25 Sep 2026
    CNIC adds an automated platform to isolate and expand CRISPR/Cas9-edited pluripotent cells

    The new equipment will facilitate work with mouse embryonic stem cells and human induced pluripotent stem cells (hiPSCs), fundamental tools for developing experimental models of cardiovascular disease
    celulas_pluripotentes
    About the CNIC
    25 Sep 2026
    CNIC adds an automated platform to isolate and expand CRISPR/Cas9-edited pluripotent cells

    The new equipment will facilitate work with mouse embryonic stem cells and human induced pluripotent stem cells (hiPSCs), fundamental tools for developing experimental models of cardiovascular disease
    The R33Q mutation in calsequestrin 2 (CASQ2) disrupts calcium control in heart cells and activates protein-degradation mechanisms.
    Research
    23 Sep 2026
    Circulation Research: A protein-degradation mechanism opens a new treatment route for an inherited arrhythmia

    Researchers at the CNIC, in collaboration with the University of Pavia and IRCCS Istituti Clinici Scientifici Maugeri, have found that activation of the enzyme calpain contributes to the development of a severe inherited arrhythmia.
    Poster “Understanding the Neurovascular Network to Prevent Dementi
    About the CNIC
    4 Sep 2026
    CNIC and Fundación Ramón Areces organise the second international conference to understand the neurovascular network and prevent dementia

    The conference “Understanding the Neurovascular Network to Prevent Dementia” will bring together leading international experts to address the role of vascular health in preventing cognitive decline and dementia
    William Joyce
    About the CNIC
    3 Sep 2026
    CNIC researcher William Joyce receives an ERC Starting Grant for the TROPOSplice project

    TROPOSplice proposes an evolution-inspired strategy to improve cardiac relaxation in patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.